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Villoglandular papillary adenocarcinoma (VPA) is a very rare subtype of adenocarcinoma of the uterine cervix, but a well-
recognized variant of cervical adenocarcinoma with a favorable prognosis and generally occurring in women of child-bearing
age. Only ﬁve cases of VPA and pregnancy have been reported. Herein, we report a case of VPA diagnosed during early pregnancy
andmanagedsuccessfullywithconservativemeasures;ourpatientdelivered ahealthybabyinfullterm.Asuccessfulpregnancy can
becompletedinpatientswithVPAwithoutlymph-vascularinvasion,whentreatedconservatively.Thismanagementisparticularly
desirable in young women to preserve reproductive capability.
1.Introduction
The incidence of cervical adenocarcinoma is on the rise over
the last decades. Villoglandular papillary adenocarcinoma
(VPA) is a very rare subtype of adenocarcinoma of the
uterine cervix. The true incidence of this form of adeno-
carcinoma is unknown. The classical histologic appearance
of this entity is a surface papillary component of variable
thickness with papillae that are usually tall and thin, but
occasionally short and broad, with a ﬁbrous stromal core.
Thetumorcellsshouldhavenomorethanmild-to-moderate
nuclear atypicality and scattered mitotic ﬁgures. It aﬀects
a younger age group and has an excellent prognosis as
compared to other endocervical adenocarcinomas [1, 2].
To our knowledge, only ﬁve cases of VPA associated with
pregnancieshavebeenreportedintheliterature[3–7].Intwo
cases, the patients were diagnosed VPA during pregnancy
followed by conservative treatment and delivered healthy
children [5, 7]. We report here a successful term pregnancy
with stage IB VPA of the cervix diagnosed during early
pregnancy.
2.CaseReport
A 28-year-old Japanese woman, gravida 1, para 1, was
admitted with atypical genital bleeding and underwent
polypectomy of the uterine cervix at 9 weeks’ gestation. The
1-cm resected polyp was pathologically diagnosed as VPA
(Figure 1). The tumor is purely exophytic without invasion
of the underlying stroma and lymphvascular involvement.
Hence, she was referred to our hospital. As the polyp had
no lymph capillary space invasion, we performed conization
at 16 weeks’ gestation when the patient decided to continue
her pregnancy. The depth of surgical specimen was 1cm
and width of that was 3cm diameter. No cancer cells were
identiﬁed in the resected specimens. The ﬁnal diagnosis was
FIGO stage IB1. She delivered a healthy 2,946g newborn
vaginally at term 38 weeks, and she has been free of the
disease for 44 months.
3. Discussion
We report an extremely rare case who was diagnosed
VPA in the 1st trimester and was managed conservatively2 Case Reports in Medicine
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Figure 1: Typical histological patterns for villoglandular papillary
adenocarcinoma of the cervix. (a) Tumor displaying thin and tall,
well-formed papillary structures (hematoxylin and eosin, original
magniﬁcation,x4),(b)Highermagniﬁcationof(a).Largeglandular
and papillary structures with broad stroma (hematoxylin and
eosin, original magniﬁcation, x40), (c) Higher magniﬁcation of (b)
(hematoxylin and eosin, original magniﬁcation, x200).
throughout the pregnancy with successful results for both
the mother and the baby. VPA of the uterine cervix is a
rare form of cervical adenocarcinoma ﬁrst described by
Young and Scully in 1989 [1]. They found that this tumor
has an excellent prognosis and suggested conization as a
potential treatment for patients of childbearing age [1].
Conservative management of cervical VPA is considered to
be a signiﬁcant challenge; however, the English literature
concerning treatment of VPA diagnosed during pregnancy
is sparse. So far, over 115 cases of cervical VPAs have
been reported worldwide; of these only nine metastases
and two deaths were reported [7–11]. These few cases
show an apparent discrepancy from the excellent prognosis
of VPA described originally by Young, Scully and others
[1, 12]. In 30% of cases, VPA is associated with other
forms of invasive cancer [1–4, 6], which may have an
important impact on the prognosis. Young and Scully
therefore reserve the term VPA for tumors in which the
villoglandular pattern is the exclusive or almost exclusive
one. It has been suggested that in cases of superﬁcial VPA
diagnosed in young patients, unassociated with another type
of cervical tumor and without lymph vascular invasion, less
radical treatment may be suitable since these cases present
a favorable outcome [12]. However, since the knowledge
of the biologic spectrum of VPA appears to be evolving, a
close follow up should be pursued in VPA patients managed
conservatively [13].
Young and Scully recommended careful inspection of
the histological specimen and if the villoglandular com-
ponent is the exclusive or almost exclusive pattern then
a diagnosis of VPA can be ascribed [1]. Other papillary
adenocarcinomascanpresentadiﬃcultyindiagnosis.Serous
papillary adenocarcinomas of the cervix have ﬁner, more
irregular and more cellular papillae than VPA. The clear cell
papillary adenocarcinomas of the cervix are characterized
by marked cytological atypia, high mitotic activity and
occasionally the presence of psammoma bodies. VPA should
be distinguished from endocervical adenocarcinoma with a
minor villoglandular component. The rare adenosarcoma
and adenoma malignum should also be considered in the
diﬀerential diagnosis of VPA [8].
Pregnancy associated with VPA of the cervix has been
reported in only ﬁve cases [3–7]. In two cases, success-
ful pregnancies were achieved following a conservative
treatment for VPA [3, 4]. Three additional cases were
diagnosed during pregnancy (Table 1); the ﬁrst case, which
was diagnosed during the 20th week of gestation, was
conservatively followed until the 32nd week of gestation,
when a caesarean radical hysterectomy was performed [5],
the second case ended with an early induced abortion (8
weeks of gestation) followed by a radical hysterectomy [6],
and the third case, which was diagnosed during the 13th
week of gestation, was conservatively followed until the 37th
week of gestation, when a caesarean radical hysterectomy
was performed [7]. In the case whose pregnancy was
terminated (8 weeks of gestation) followed by a radical
hysterectomy, the patient underwent second, third and
fourth laparotomies because of recurrent pelvic masses. At
the end of ﬁve years follow-up period, she died because
of the complication of recurrent tumor [6]. Bouman et al.
reported three cases of VPA, and two of these are malicious
because they have other histological features (the ﬁrst case
showed well-diﬀerentiated adenocarcinoma with abundant
squamous diﬀerentiation, and the second case has well to
moderately diﬀerentiated papillary adenocarcinoma) [14].
These authors recommend the attitude, “Beware of a wolf
in sheep’s clothing”, in relation to VPA [14]. However, we
can not discuss the clinical outcome in pregnant patients,
because there is no report of VPA accompanied with other
histological features or extended tumor invasion in pregnant
patients.Case Reports in Medicine 3
Table 1: Proﬁle of patients with villoglandular papillary adenocarcinoma diagnosed in pregnancy.
Reference Present case [5][ 6][ 7]
A g e 2 82 22 83 1
G r a v i d a 1332
P a r a 1221
Gestational age at diagnosis (weeks) 9 20 8 13
Gestational age at delivery (weeks) 38 32 8 37
Mode of delivery VD C/S Termination C/S
Macroscopic feature Polypoid Polypoid Polypoid Polypoid
FIGO stage IB1 IB2 IB1 IB1
Treatment Conization RH RH RH
L C S I ————
Lymph node metastasis Not examined — Not examined —
F o l l o w - u p ( m o n t h s ) 3 81 46 01 8
Outcome NED NED DOD NED
VD: vaginal delivery; C/S: cesarean section; FIGO: F´ ed´ eration Internatinale de Gyn´ ecologie et d’Obst´ etrique; RH: radical hysterectomy; LCSI: lymph capillary
space invasion; NED: no evidence of disease; DOD: dead of disease.
In conclusion, despite the limited experience of cervical
VPA diagnosed during pregnancy, conservative treatment
can be successfully achieved in selected patients after a
thorough evaluation of the depth of invasion, the lymph
vascularinvolvement,andtheassociationofothercarcinoma
histologies in conjunction with the VPA (i.e. adenocarci-
noma or squamous cell carcinoma).
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